参照論文：CBDと 疼痛

• Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain
• Sativex: Clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain
• Cannabis, pain, and sleep: Sativex Clinical Trials
• Sativex successfully treats neuropathic pain characterised by allodynia: clinical trial
• Cannabinoids for neuropathic pain
• Neuropathic orofacial pain: Cannabinoids as a therapeutic avenue
• Oromucosal delta9-THC/CBD for neuropathic pain associated with multiple sclerosis
• The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain
• Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation
• Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy
• Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain
• Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action
• Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
• Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes
• Cannabinoids in the management of difficult to treat pain
• Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain
• Marijuana extract helps prevent chemo pain
• Pot users less likely to take painkillers
• CBD & THC interactions on acute pain and locomotor activity
• CBD is a potential therapeutic for the affective-motivational dimension of incision pain in rats

上のリンクは、第三者のウェブサイトにある記事を参考のために掲載しています。